ADENTRA (ADEN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 sales reached $597.1 million, up 8.7% year-over-year, driven by the Wolf/Woolf Distributing acquisition and steady organic sales.
Adjusted EBITDA rose 12% to $54.3 million, with adjusted EPS at $0.88 and basic EPS at $0.89.
Gross margin improved to 21.8%, with operating expenses down 3.9%.
Cash flow from operations was $33.9 million, supporting debt reduction and $11.2 million in shareholder returns.
The company remains resilient amid soft construction markets, focusing on disciplined execution and long-term EPS growth.
Financial highlights
US sales grew 9.3% to $551.6 million, mainly from the Wolf/Woolf acquisition; Canadian sales rose 2.8% to C$63.1 million.
Gross profit was $130.1 million (up 9.1%), with gross margin at 21.8%.
Q2 net income was $22.1 million, up 29.9% year-over-year; adjusted net income fell 6.7% to $21.9 million due to higher interest and tax expenses.
Operating cash flow was $33.9 million, up from $23.8 million in Q2 last year.
Six-month sales increased 5.1% to $1.14 billion, with gross margin up 4.0% to $247.1 million.
Outlook and guidance
Inventory is expected to decline in the second half, improving leverage to the mid-teens range by year-end.
July average daily sales tracked about 4% below Q2 levels, with some improvement in the latter half of the month.
Long-term fundamentals in residential construction remain positive, with focus on disciplined execution and adaptability.
Strategic priorities include driving double-digit returns and acquisitive growth through platform efficiency, organic initiatives, and targeted M&A.
Strong cash generation expected in H2, with priorities on reducing leverage and strengthening the balance sheet.
Latest events from ADENTRA
- Margin and EPS growth, M&A, and digital initiatives drive stable outlook and long-term growth.ADEN
Q2 202427 Apr 2026 - Sales up 1.8% to $568.8M, net income up 28.7%, gross margin 21.3%, and dividend increased.ADEN
Q3 202427 Apr 2026 - Q4 sales and margins improved, net income rose, and M&A expanded reach despite headwinds.ADEN
Q4 202427 Apr 2026 - Sales up 1.4% from acquisition, but organic sales and earnings declined amid macro headwinds.ADEN
Q1 202527 Apr 2026 - Q3 sales rose 4.1% to $592.1M, with margin gains and strong cash flow despite market headwinds.ADEN
Q3 202527 Apr 2026 - Sustained growth, strategic acquisitions, and operational excellence drive long-term value creation.ADEN
Investor presentation16 Mar 2026 - Strong growth, disciplined M&A, and operational excellence drive double-digit returns.ADEN
Investor presentation16 Mar 2026 - 2025 sales and net income grew, with robust cash flow, higher margins, and increased dividends.ADEN
Q4 202512 Mar 2026 - Sustained growth, strong M&A, and operational excellence drive double-digit shareholder returns.ADEN
Investor Presentation7 Aug 2025